The creation of the Alliance is an extraordinary accomplishment in global collaboration that only serves to further the mission of all of its members with the ultimate goal of promoting excellence in patient care.
Milwaukee, WI (PRWEB) October 18, 2016
The Clinical Immunology Society (CIS) announces a partnership with four international societies focused on primary immunodeficiency representing the five major continents. Together they have formed the International Alliance for Primary Immunodeficiency Societies (IAPIDS).
The agreement made by the Asia-Pacific Society of Immunodeficiencies (APSID), African Society for Immunodeficiencies (ASID), European Society for Immunodeficiencies (ESID), the Latin American Society for Immunodeficiencies (LASID), as well as the CIS was signed and announced at the ESID Annual Meeting in Barcelona, Spain on September 21, 2016.
“The creation of the Alliance is an extraordinary accomplishment in global collaboration that only serves to further the mission of all of its members with the ultimate goal of promoting excellence in patient care,” said CIS President Jordan Orange, MD, PhD.
The IAPIDS exists to advance the member professional societies in education of those engaged in the care of PID patients and promote member societies in disseminating and advancing the basic, translational and clinical science of PID and related knowledge all in the name of advancing the well-being and care of patients affected by PID and related conditions.
For additional information on the CIS and the IAPIDS, contact Morgan Derby at (414) 224-8095 or mderby(at)clinimmsoc(dot)org.
ABOUT THE CLINICAL IMMUNOLOGY SOCIETY:
The Clinical Immunology Society (CIS), established in 1986, is devoted to fostering developments in the science and practice of clinical immunology. The primary objectives and purposes of this Society are to:
- Facilitate the interchange of ideas and information among physicians and other investigators who are concerned with immunological/inflammatory diseases;
- Promote research on the causes and mechanisms of diseases relating to the immune system and, as a result, to unify concepts of disease pathogenesis;
- Encourage investigators and clinicians to share in their knowledge of immunologically active drugs and other interventions;
- Promote application and dissemination of recent advances in biomedical science for the prevention, diagnosis and treatment of diseases related to immunity and inflammation; and
- Foster excellence in research and medical practice.
For more information, visit http://www.clinimmsoc.org.